IMCD N.V. (NL:IMCD)
:IMCD
Want to see NL:IMCD full AI Analyst Report?
IMCD Stock Chart & Stats
€95.40
-€4.60(-3.24%)
At close: 4:00 PM EST
€95.40
-€4.60(-3.24%)
Day’s Range― - ―
52-Week Range€68.14 - €123.95
Previous CloseN/A
Volume200.91K
Average Volume (3M)255.76K
Market Cap
€5.41B
Enterprise Value€6.88B
Total Cash (Recent Filing)€238.59M
Total Debt (Recent Filing)€1.70B
Price to Earnings (P/E)13.0
Beta1.04
Next Earnings
Jul 29, 2026EPS Estimate
3.36Next Dividend Ex-DateN/A
Dividend Yield2.83%
Share Statistics
EPS (TTM)3.69
Shares Outstanding59,107,998
10 Day Avg. Volume216,740
30 Day Avg. Volume255,764
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)2.24
Price to Sales (P/S)0.96
P/FCF Ratio14.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€110.20Price Target Upside15.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)5.37
Revenue Forecast (FY)€5.06B
Bulls Say, Bears Say
Bulls Say
Business Model & Market ReachIMCD’s distributor model and local technical teams create durable customer lock-in across pharmaceuticals, food, personal care and more. Deep supplier authorizations and application support enable recurring sales, cross-selling and higher switching costs, supporting stable revenue over months to years.
Free Cash Flow QualityConsistent one-to-one free cash flow conversion indicates high earnings quality and strong cash generation. This durability supports reinvestment, dividend funding and debt reduction even if margins wobble, preserving financial flexibility and operational resilience over the medium term.
Multi-year Revenue ExpansionA multi-year top-line expansion through 2024 evidences successful market penetration and product distribution scale. That historical growth reflects durable commercial capabilities and diversified end-markets that can support recovery after the 2025 dip and underpin medium-term growth when margins stabilize.
Bears Say
Margin Deterioration (2025)Material gross and operating margin compression in 2025 signals sustained pricing pressure, unfavorable mix, or cost inflation that can erode long-term profitability. If margins do not recover, cash generation and return on capital will be structurally weaker, limiting reinvestment capacity.
Elevated LeverageDebt-to-equity rising into the high 0.7–0.8x range reduces balance-sheet flexibility and raises refinancing and interest-rate exposure. Higher leverage constrains ability to fund M&A, absorb shocks or step up investment, increasing downside risk if earnings or cash flow weaken further.
Declining EPS / Capital EfficiencyA near-25% EPS decline signals weakening profitability and return on equity trends. Persistently falling EPS and ROE reduce capacity for shareholder returns and weaken the firm’s ability to self-fund strategic initiatives, making long-term earnings recovery more challenging.
IMCD N.V. News
IMCD FAQ
What was IMCD N.V.’s price range in the past 12 months?
IMCD N.V. lowest stock price was €68.14 and its highest was €123.95 in the past 12 months.
What is IMCD N.V.’s market cap?
IMCD N.V.’s market cap is €5.41B.
When is IMCD N.V.’s upcoming earnings report date?
IMCD N.V.’s upcoming earnings report date is Jul 29, 2026 which is in 69 days.
How were IMCD N.V.’s earnings last quarter?
IMCD N.V. released its earnings results on Apr 30, 2026. The company reported €1.46 earnings per share for the quarter, beating the consensus estimate of N/A by €1.46.
Is IMCD N.V. overvalued?
According to Wall Street analysts IMCD N.V.’s price is currently Undervalued.
Does IMCD N.V. pay dividends?
IMCD N.V. pays a Annually dividend of €2.15 which represents an annual dividend yield of 2.83%. See more information on IMCD N.V. dividends here
What is IMCD N.V.’s EPS estimate?
IMCD N.V.’s EPS estimate is 3.36.
How many shares outstanding does IMCD N.V. have?
IMCD N.V. has 59,107,998 shares outstanding.
What happened to IMCD N.V.’s price movement after its last earnings report?
IMCD N.V. reported an EPS of €1.46 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.014%.
Which hedge fund is a major shareholder of IMCD N.V.?
Currently, no hedge funds are holding shares in NL:IMCD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IMCD N.V.
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
IMCD Stock 12 Month Forecast
Average Price Target
€110.20
▲(15.51% Upside)
Technical Analysis
Options Prices
Currently, No data available
---